Contrast-enhanced magnetic resonance imaging in the follow-up of subendocardial myocardial damage in patients with drug-resistant arterial hypertension treated using radiofrequencey ablation of renal arteries

The aim of the study was to adopt and optimise the technique of contrast-enhanced magnetic resonance tomography for evaluation of non-transmural damage of myocardium in patients with drug-resistant arterial hypertension in the course of treatment using intravascular technique of radiofrequency ablation of the renal arteries. ECG-gated contrast-enhanced MRI of the heart was employed for these purposes in ten patients with drug-resistant hypertension and prominent left ventricular hypertrophy twice: before the treatment and six months after radiofrequency ablation of the renal arteries. The index of enhancement (IE) of T1-weighted spin-echo images, volume of uptake of the contrast to the myocardium, and left ventricular myocardial mass were shown as most useful indices for the MRI follow-up of condition of the heart in the patients. The study showed that contrast-enhanced MRI is an adequate technique of diagnosis and follow-up of the non-transmural damage of myocardium in patients with left ventricular hypertrophy and drug-resistant arterial hypertension. Results of the MRI studies in these patients with drug-resistant hypertension provide evidence for significant regress of left ventricular hypertrophy and subendocardial myocardial damage after radiofrequency ablation of the renal arteries.

контрастированная магнитно-резонансная томография миокарда, резистентная артериальная гипертония, субэндокардиальное повреждение миокарда, радиочастотная аблация почечных артерий, contrast-enhanced MRI of the heart, drug-resistant arterial hypertension, subendocardial myocardial damage, radiofrequency ablation of renal arteries

1. Чазова И.Е., Ощепкова Е.В., Рогоза А.Н. и др. Диагностика и лечение артериальной гипертонии. Клинические рекомендации. - М.: Министерство здравоохранения Российской Федерации, 2013. - 64 с.

2. Ларина О.М. Диагностическое значение магнитно-резонансной томографии при гипертрофии миокарда левого желудочка различного генеза. Литературный обзор // Вестник РНЦРР МЗ РФ. - 2010. - № 10 - С. 36-42.

3. Усов В.Ю. Парамагнитное контрастирование при магнитно-резонансной томографии миокарда у пациентов с ишемической болезнью сердца. - Томск: STT, 2012. - 104 с.

4. Фомина И.Г., Дьякова Т.А. Гипертрофия левого желудочка при артериальной гипертензии и риск развития аритмий // Кардиоваскулярная терапия и профилактика. - 2006. -Т. 5(8). - С. 83-89.

5. Bhatt D.L., Kandzari D.E., O’Neill W.W. et al. A Controlled Trial of Renal Denervation for Resistant Hypertension // N. Engl. J. Med. - 2014, Mar 29. (Epub ahead of print).

6. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method // Circulation. - 1977. - Vol. 55. - P. 613-618.

7. Esler M.D., Krum H., Schlaich M. et al. SYMPLICITY HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the SYMPLICITY HTN-2 randomized, controlled trial // Circulation. - 2012. - Vol. 126(25). - P. 2976-2982.

8. Leong K.T., Walton A., Krum H. Renal sympathetic denervation for the treatment of refractory hypertension // Ann. Rev. Med. - 2014. - Vol. 65. - P. 349-365.